| Product Name | MF | CAS | Details |
|---|
| LIMK1 inhibitor BMS-4 | C23H23N7O2S | 905298-84-2 | Details |
| Endomorphin 1 acetate | C36H42N6O7 | 1276123-71-7 | Details |
| AChE/Nrf2 modulator 1 | C27H27FN4O2 | 2417117-84-9 | Details |
| 5-Cyclopropylpentanal | C8H14O | 147159-38-4 | Details |
| Antimalarial agent 20 | C31H38N4O3 | 1422207-75-7 | Details |
| CB1 inverse agonist 2 | C24H20ClFN2OS | 1019839-52-1 | Details |
| LRRK2/NUAK1/TYK2-IN-1 | C20H11F3N6 | 2629192-96-5 | Details |
| Aliskiren fumarate | C34H57N3O10 | 1196835-68-3 | Details |
| Sirtuin modulator 4 | C18H10N2O2S | 327104-77-8 | Details |
| HIV-1 inhibitor-10 | C39H54O6 | 1449660-81-4 | Details |
| 6-Fluoromevalonate | C6H9FO3 | 2822-77-7 | Details |
| RORγt inhibitor 2 | C31H33F5N2O7S | 2673278-10-7 | Details |
| A2AR-antagonist-1 | C27H25N5O2 | 2922920-71-4 | Details |
| PRRSV/CD163-IN-1 | C25H24FN5O5S2 | 560995-89-3 | Details |
| SARS-CoV-2-IN-12 | C30H41N5O7.C2HF3O2 | 2721455-52-1 | Details |
| PD-1/PD-L1-IN-26 | C43H52N4O8 | 2966090-78-6 | Details |
| (R)-PD 0325901CL | C16H14ClF2IN2O4 | 1003216-77-0 | Details |
| Cefepime chloride | C19H25ClN6O5S2 | 107648-79-3 | Details |
| (R)-Elsubrutinib | C17H19N3O2 | 1643570-23-3 | Details |
| PD-1/PD-L1-IN-27 | C44H35NO6 | 2891831-47-1 | Details |
| SIRT5 inhibitor 5 | C21H14ClN3O3S | 2883730-60-5 | Details |
| Broussochalcone A | C20H20O5 | 99217-68-2 | Details |
| Mcl-1 inhibitor 9 | C32H39ClN2O5S | 1883727-31-8 | Details |
| AT1R antagonist 1 | C28H32F3N5O4S2 | 2848719-80-0 | Details |
| Antitumor agent-87 | C22H28N2O6S | 1422527-88-5 | Details |
| GnRH-R antagonist 1 | C31H28F5N7O6S | 2826273-90-7 | Details |
| Umbralisib tosylate | C38H32F3N5O6S | 1532533-72-4 | Details |
| EFdA-TP tetrasodium | 2883783-00-2 | Details |
| NOD1/2 antagonist-1 | C32H28ClF5N4O4 | 2704623-69-6 | Details |
| Anticancer agent 100 | C18H20ClN3O | 2914922-73-7 | Details |
| SARS-CoV MPro-IN-2 | C13H10O4 | 81418-42-0 | Details |
| Tubulin inhibitor 30 | C22H19N3O5 | 2873383-67-4 | Details |
| Z-LE(OMe)TD(OMe)-FMK | C30H43FN4O11 | 210344-93-7 | Details |
| Thrombin inhibitor 6 | C18H19ClN4O2S | 1628224-94-1 | Details |
| Calpain Inhibitor XI | C19H29N3O4 | 145731-49-3 | Details |
| Influenza virus-IN-6 | C27H26ClNO7 | 2919303-26-5 | Details |
| Plm IV inhibitor-2 | C39H54N4O4 | 1539276-38-4 | Details |
| Anticancer agent 99 | C19H20F3N3O2 | 2914922-83-9 | Details |
| IRE1α kinase-IN-7 | C28H25F3N6O | 1414938-22-9 | Details |
| Transketolase-IN-2 | C18H9F3N2O3S | 2757552-21-7 | Details |
| iNOS inhibitor-10 | C22H23N3O2S | 2918773-63-2 | Details |
| HIV-1 inhibitor-50 | C24H18FN5O2 | 2834087-69-1 | Details |
| Axl/Mer/CSF1R-IN-1 | C25H24F3N5O5 | 2394874-60-1 | Details |
| IACS-8779 disodium | C21H26N9NaO10P2S2 | 2243079-27-6 | Details |
| Lapatinib tosylate | C36H34ClFN4O7S2 | 1187538-35-7 | Details |
| Niclosamide sodium | C13H9Cl2N2NaO4 | 40321-86-6 | Details |
| Umbralisib sulfate | C31H26F3N5O7S | 1532533-75-7 | Details |
| A3AR antagonist 2 | C22H16N6O3 | 1144161-05-6 | Details |
| ERK-IN-2 free base | C16H17N5O2 | 2743576-55-6 | Details |
| GR 89696 free base | C19H25Cl2N3O3 | 126766-31-2 | Details |
| MRS2279 diammonium | C13H21ClN6O8P2 | 2387505-47-5 | Details |
| Lck Inhibitor III | C25H30N6O4 | 1188890-30-3 | Details |
| 4-Formylcolchicine | C23H25NO7 | 2730-82-7 | Details |
| Anticancer agent 66 | C26H23Cl2FN6O2S2 | 2691895-64-2 | Details |
| Antioxidant agent-2 | C23H26N2O7 | 2250106-92-2 | Details |
| HIV-1 inhibitor-53 | C30H34N2O8S | 2883496-10-2 | Details |
| GPR84 antagonist 2 | C28H18Cl2NaO4PS2 | 2244269-74-5 | Details |
| Multi-kinase-IN-1 | C35H36F2N6O6S | 2470807-67-9 | Details |
| c-Myc inhibitor 8 | C19H12BrClF3NO3S2 | 2173505-97-8 | Details |
| STING modulator-3 | C18H17N9O | 2839639-94-8 | Details |
| IL-17 modulator 5 | C28H23F6N9O2 | 2724206-27-1 | Details |
| c-Myc inhibitor 9 | C27H31N5OS | 2799717-96-5 | Details |
| BTK inhibitor 20 | C37H42N8O4 | 2696450-27-6 | Details |
| ATX inhibitor 17 | C29H29F5N8S | 2750152-64-6 | Details |
| P-gp inhibitor 4 | C38H38N2O8S2 | 2652001-05-1 | Details |
| URAT1 inhibitor 4 | C27H20BrN3O4S3 | 2700292-02-8 | Details |
| GLP-1R agonist 17 | C28H26ClFN4O4S | 2749609-28-5 | Details |
| Palmatine hydroxide | C21H22NO4.HO | 131-04-4 | Details |
| Anticancer agent 25 | C37H45N2O3.Br | 2401013-08-7 | Details |
| Crozbaciclib fumarate | C32H34F2N6O4 | 2567494-39-5 | Details |
| LDC4297 hydrochloride | C23H29ClN8O | 2319747-14-1 | Details |
| (S)-LY3177833 hydrate | C16H14FN5O2 | 2733342-93-1 | Details |
| Dihydro-β-erythroidine | C16H21N1O3 | 23255-54-1 | Details |
| Sortilin antagonist 1 | C20H24N2O4 | 2691846-93-0 | Details |
| PI3K/mTOR Inhibitor-5 | C32H40N10O3 | 2456295-60-4 | Details |
| PARP11 inhibitor ITK7 | C17H14N4OS | 2411890-36-1 | Details |
| PI3K/mTOR Inhibitor-13 | C20H13F2N5O3S | 1621718-37-3 | Details |
| 3-Oxo-hop-22(29)-ene | C30H48O | 25615-11-6 | Details |
| KRAS G12D inhibitor 3 | C34H31ClF3N5O2 | 2757095-11-5 | Details |
| PfGSK3/PfPK6-IN-2 | C24H25Cl2N5OS | 2797225-47-7 | Details |
| Aurora Kinases-IN-3 | C20H16F3N3O4 | 2840558-83-8 | Details |
| LTB4 antagonist 1 | C26H23NO6 | 2929239-84-7 | Details |
| Isoandrographolide | C20H30O5 | 4176-96-9 | Details |
| HIV-1 inhibitor-52 | C46H72FNO5S | 1818868-23-3 | Details |
| Dihydroaltenuene B | C15H18O6 | 887751-89-5 | Details |
| GLS1 Inhibitor-4 | C29H27F3N10O2S2 | 2768599-97-7 | Details |
| RORγt modulator 5 | C27H22F5N3O6S | 2119042-65-6 | Details |
| GCGR antagonist 2 | C28H26N4O2 | 280134-25-0 | Details |
| Ferroptosis inducer-1 | C25H21ClN2O5 | 2375357-96-1 | Details |
| Efflux inhibitor-1 | C28H25N5O3 | 1776055-29-8 | Details |
| SARS-CoV-2 Mpro-IN-6 | C18H18Cl3N3O2S | 2768834-48-4 | Details |
| IL-17A modulator-3 | C34H50FN7O4 | 2467732-95-0 | Details |
| Antiviral agent 23 | C18H21N5O4 | 35940-03-5 | Details |
| Antitumor agent-88 | C23H30N2O7S | 1422527-87-4 | Details |
| Antitumor agent-81 | C19H19N7O3 | 2765180-17-2 | Details |
| CBB1007 hydrochloride | C27H34N8O4.5ClH | 2070014-96-7 | Details |
| Kallikrein 5-IN-2 | C23H22N6O | 2361160-57-6 | Details |
| STING modulator-4 | C17H18N8O | 2839639-72-2 | Details |
| Anticancer agent 53 | C31H25FN4O6S | 1926985-18-3 | Details |
| A1AT modulator 2 | C27H22FN3O3 | 2555004-05-0 | Details |
| Product Total： Product Page： | ||||
| 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 | ||||